Sandro La Vignera1, Roberto Vita2, Rosita A Condorelli3, Laura M Mongioì3, Silvia Presti2, Salvatore Benvenga2,4,5, Aldo E Calogero3. 1. Department of Clinical and Experimental Medicine, University of Catania, Policlinico "G. Rodolico", Via Santa Sofia 78, 95123, Catania, Italy. sandrolavignera@unict.it. 2. Endocrinology, Department of Clinical and Experimental Medicine, University of Messina, Policlinico Universitario di Messina, Padiglione H, 4th floor, Viale Gazzi, 98125, Messina, Italy. 3. Department of Clinical and Experimental Medicine, University of Catania, Policlinico "G. Rodolico", Via Santa Sofia 78, 95123, Catania, Italy. 4. Master Program on Childhood, Adolescence & Women's Endocrine Health, University of Messina, Viale Gazzi, 98125, Messina, Italy. 5. Interdepartmental Program of Molecular & Clinical Endocrinology and Women's Endocrine Health, A.O.U. Policlinico G. Martino, Viale Gazzi, 98125, Messina, Italy.
Abstract
INTRODUCTION: Testis was considered unresponsive to thyroid hormone for a long time. However, like in animals, the presence of thyroid hormone receptors in different testicular cell types was demonstrated also in humans. Accordingly, thyrotoxicosis and hypothyroidism have remarkable effects on testicular function and more extensively on fertility. REVIEW: Thyrotoxicosis and hypothyroidism are associated with changes affecting the endocrine, sexual, or reproductive functions. Particularly, compared with controls, hyperthyroid patients have higher serum SHBG and lower free and bioavailable testosterone concentrations, a higher rate of astheno-zoospermia, oligo-zoospermia, and terato-zoospermia, and a higher prevalence of sexual disturbances, such as premature ejaculation. In hypothyroid patients, hormonal changes are in the opposite direction compared with hyperthyroid patients. Thyroid hormone regulates a number of functions in the testis, such as proliferation and differentiations of non-germ cells, steroidogenesis, and sperm motility. Furthermore, thyroid hormone regulates testicular redox status. Consequently, thyroid hormone excess or deficiency can affect testicular function at different levels. CONCLUSIONS: In view of the high prevalence of thyrotoxicosis and hypothyroidism, a considerable part of infertile patients may harbor overt or subclinical thyroid disease. Identification and management of thyrotoxicosis/hypothyroidism associated infertility needs the collaboration of andrologists, endocrinologists, gynecologists, and general practitioners.
INTRODUCTION: Testis was considered unresponsive to thyroid hormone for a long time. However, like in animals, the presence of thyroid hormone receptors in different testicular cell types was demonstrated also in humans. Accordingly, thyrotoxicosis and hypothyroidism have remarkable effects on testicular function and more extensively on fertility. REVIEW: Thyrotoxicosis and hypothyroidism are associated with changes affecting the endocrine, sexual, or reproductive functions. Particularly, compared with controls, hyperthyroidpatients have higher serum SHBG and lower free and bioavailable testosterone concentrations, a higher rate of astheno-zoospermia, oligo-zoospermia, and terato-zoospermia, and a higher prevalence of sexual disturbances, such as premature ejaculation. In hypothyroidpatients, hormonal changes are in the opposite direction compared with hyperthyroidpatients. Thyroid hormone regulates a number of functions in the testis, such as proliferation and differentiations of non-germ cells, steroidogenesis, and sperm motility. Furthermore, thyroid hormone regulates testicular redox status. Consequently, thyroid hormone excess or deficiency can affect testicular function at different levels. CONCLUSIONS: In view of the high prevalence of thyrotoxicosis and hypothyroidism, a considerable part of infertilepatients may harbor overt or subclinical thyroid disease. Identification and management of thyrotoxicosis/hypothyroidism associated infertility needs the collaboration of andrologists, endocrinologists, gynecologists, and general practitioners.
Authors: David M Selva; Lluis Bassas; Francina Munell; Ana Mata; Francis Tekpetey; John G Lewis; Geoffrey L Hammond Journal: J Clin Endocrinol Metab Date: 2005-08-30 Impact factor: 5.958
Authors: S La Vignera; G Defeudis; R Mazzilli; S Medenica; A M Di Tommaso; G Fabozzi; V Zamponi; D Cimadomo; L Rienzi; F M Ubaldi; M Watanabe; A Faggiano Journal: J Endocrinol Invest Date: 2022-08-09 Impact factor: 5.467
Authors: Alisa D Kjaergaard; Eirini Marouli; Areti Papadopoulou; Panos Deloukas; Aleksander Kuś; Rosalie Sterenborg; Alexander Teumer; Stephen Burgess; Bjørn O Åsvold; Daniel I Chasman; Marco Medici; Christina Ellervik Journal: Eur J Epidemiol Date: 2021-02-06 Impact factor: 12.434
Authors: Ali S Alzahrani; Mourad Al Mourad; Kevin Hafez; Abdulrahman M Almaghamsy; Fahad Abdulrahman Alamri; Nasser R Al Juhani; Alhussien Sagr Alhazmi; Mohammad Yahya Saeedi; Saud Alsefri; Musa Daif Allah Alzahrani; Nadia Al Ali; Wiam I Hussein; Mohamed Ismail; Ahmed Adel; Hisham El Bahtimy; Eslam Abdelhamid Journal: Adv Ther Date: 2020-06-01 Impact factor: 3.845
Authors: Anders Funkquist; Anders Bengtsson; P M Johansson; Johan Svensson; Per Bjellerup; Kaj Blennow; Birger Wandt; Stefan Sjöberg Journal: J Clin Transl Endocrinol Date: 2020-02-04